0001127602-20-030240.txt : 20201201
0001127602-20-030240.hdr.sgml : 20201201
20201201170652
ACCESSION NUMBER: 0001127602-20-030240
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201130
FILED AS OF DATE: 20201201
DATE AS OF CHANGE: 20201201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zaks Tal Zvi
CENTRAL INDEX KEY: 0001690927
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 201361549
MAIL ADDRESS:
STREET 1: 122 BELLEVUE STREET
CITY: NEWTON
STATE: MA
ZIP: 02458
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-11-30
0001682852
Moderna, Inc.
MRNA
0001690927
Zaks Tal Zvi
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
Chief Medical Officer
Common Stock
2020-11-30
4
M
0
5000
12.21
A
5000
D
Common Stock
2020-11-30
4
M
0
5000
14.22
A
10000
D
Common Stock
2020-11-30
4
M
0
10000
19.15
A
20000
D
Common Stock
2020-11-30
4
S
0
800
142.43
D
19200
D
Common Stock
2020-11-30
4
S
0
600
144.09
D
18600
D
Common Stock
2020-11-30
4
S
0
1660
145.25
D
16940
D
Common Stock
2020-11-30
4
S
0
2108
146.12
D
14832
D
Common Stock
2020-11-30
4
S
0
3335
147.22
D
11497
D
Common Stock
2020-11-30
4
S
0
5893
148.35
D
5604
D
Common Stock
2020-11-30
4
S
0
4100
149.38
D
1504
D
Common Stock
2020-11-30
4
S
0
700
150.09
D
804
D
Common Stock
2020-11-30
4
S
0
100
151.00
D
704
D
Common Stock
2020-11-30
4
S
0
312
152.74
D
392
D
Common Stock
2020-11-30
4
S
0
392
153.50
D
0
D
Stock Option (Right to Buy)
12.21
2020-11-30
4
M
0
5000
0
D
2027-02-23
Common Stock
5000
12945
D
Stock Option (Right to Buy)
14.22
2020-11-30
4
M
0
5000
0
D
2028-02-28
Common Stock
5000
55209
D
Stock Option (Right to Buy)
19.15
2020-11-30
4
M
0
10000
0
D
2026-08-10
Common Stock
10000
24790
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.21 to $142.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.63 to $144.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.65 to $145.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.67 to $146.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.70 to $147.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.85 to $148.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.93 to $149.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.94 to $150.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.35 to $153.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.40 to $153.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.
25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.
This option is fully vested and exercisable.
/s/ Lori Henderson, as Attorney-in-Fact
2020-12-01